Additionally, LIPUS-guided gene therapy has been used to transiently enhance tumor perfusion, thereby promoting the delivery of liposomal drugs in neuroblastoma via inducible nitric oxide synthase (iNOS) expression 62. This evidence concerns the gene NOS2 and neuroblastoma.